BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, February 10, 2025
See today's BioWorld Asia
Home
» Regulatory actions for Aug. 8-14, 2023
To read the full story,
subscribe
or
sign in
.
Regulatory actions for Aug. 8-14, 2023
Aug. 15, 2023
No Comments
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Ascentage, Astellas, Biocity, Huidagene, Iveric, Jacobio, Lemonex, Oricell, Pyc, Zumutor.
BioWorld Asia
Briefs
Regulatory actions